Hearts from Hep-C donors: a lifesaving gamble?
NCT ID NCT03383419
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 18 times
Summary
This study tests whether hearts from donors with hepatitis C can be safely transplanted into people without the virus. Recipients will take antiviral medication to prevent infection. The goal is to expand the donor pool and improve survival for people with heart failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor University Medical Center
RECRUITINGDallas, Texas, 75246, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Cedars-Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Duke University Medical Center
ACTIVE_NOT_RECRUITINGDurham, North Carolina, 27705, United States
Conditions
Explore the condition pages connected to this study.